Interestingly, it was later reported that two CpG sites within SST’s first exon could detect colorectal, gastric, and esophageal cancer with 59.3% sensitivity and 72.8% specificity using tissue samples of 229 patients [123]. The gene discussed is SST; the disease is esophageal cancer.